Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)

NCT01244503 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01244503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01244503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2011
Completion date
June 30, 2012
Enrollment
61 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, nonalcoholic fatty liver disease